4Ferenci P, Lockwood A, Mullen K, et al. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the llth World Congresses of Gastroenterology, Vienna, 1998. Hepatology, 2002, 35: 716-721.
5Rama Rao KV, Jayakumar AR, Norenberg MD. Ammonia neurotoxicity role of the mitochondrial permeability transition. Metab Brain Dis, 2003, 18: 113-127.
6Rama Rao KV, Chen M, Simard JM, et al. Increased aquaporin expression in ammonia-treated cultured astrocytes. Neuroreport, 2003, 14: 2379-2382.
7Jayakumar AR, Rama Rao NV, Schousboe A, et al. Glutamine-induced free radical production in cultured astrocytes. Glia, 2004, 46:296-301.
8Kim Y. High signal intensities on T1 weighted MR I as a hiomarker of exposure to manganese. Industrial Health, 2004, 42: 111.
9Gupta RK, Dhiman RK. Magneitc resonance imaging and spectroscopy in hepatic encephalopathy. Indian J Gastroenterology, 2003, 22(Supple 2) : 45.
10Spahr L, Butterworth RF, Fontaine S, et al. Increased blood manganese in cirrhotic patients relationship to pallidal magnetic resonance signal hyperintensity and neurological symptoms. Hepatology, 1996, 24: 1116.
